Construction method and identification method of characteristic chromatogram of amaranaceae traditional Chinese medicine material or preparation thereof

Through high-performance liquid chromatography analysis method, ferulic acid was used as a reference to construct the characteristic map of the traditional Chinese medicine materials of Amaranthaceae, solving the problems of long detection and low characteristic peak resolution in the existing technology, and achieving rapid and accurate Identification and quality control of traditional Chinese medicine and its preparations.

CN118937503AActive Publication Date: 2024-11-12GUANGDONG YIFANG PHARMA +1

Patent Information

Application Number
CN202310541506.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-12
Publication Date
2024-11-12
Estimated Expiration
2043-05-12

AI Technical Summary

Technical Problem

The existing detection methods of Amaranth Chinese herbal medicines take a long time, have low characteristic peak resolution, and it is difficult to accurately reflect the quality characteristics of the cockscomb herbal medicines. Moreover, the Chinese herbal formula particles have lost the shape, color and texture identification characteristics of the original medicinal materials, and need to pass standard soup. Quality control of agents.

Method used

Using ferulic acid as a reference, high-performance liquid chromatography analysis method, using gradient elution of methanol and phosphoric acid solution, to construct a characteristic map of Amaranth Chinese herbal medicine or its preparations, including cockscomb and green anime herbal medicines, standard decoctions, Detection and identification of formula particles.

Benefits of technology

The feature map construction is realized in short detection time and good characteristic peak resolution, which can quickly and comprehensively reflect the chemical characteristics of the test products, ensuring the identification accuracy and quality control of traditional Chinese medicine and its preparations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118937503A_ABST
    Figure CN118937503A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of traditional Chinese medicine analysis, in particular to a construction method and an identification method of a specific chromatogram of an amaranaceae traditional Chinese medicine material or a preparation thereof, and the amaranaceae traditional Chinese medicine material or the preparation thereof comprises a cockscomb medicinal material, a cockscomb standard decoction, cockscomb traditional Chinese medicine formula granules, a feather cockscomb flower medicinal material, a feather cockscomb flower standard decoction and feather cockscomb flower traditional Chinese medicine formula granules. In the technical scheme provided by the invention, the conditions of high performance liquid chromatography analysis are as follows: methanol is taken as a mobile phase A, a phosphoric acid aqueous solution with the volume concentration of 0.08-0.12% is taken as a mobile phase B for gradient elution, the analysis time consumption is short, the obtained characteristic peak has good separation degree and stable base line, and the chemical information of a test substance can be comprehensively reflected and is used for identifying the variety, quality, authenticity and the like of the test substance.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of traditional Chinese medicine analysis, and specifically to a method for constructing a characteristic spectrum of Amaranthaceae Chinese medicinal materials or their preparations and a method for identifying the same. The Amaranthaceae Chinese medicinal materials or their preparations include: Celosia cristata medicinal materials, Celosia standard decoction, Celosia Chinese medicinal formula granules, Amaranthus aurantifolia medicinal materials, Amaranthus aurantifolia standard decoction, Amaranthus aurantifolia Chinese medicinal formula granules. Background Art

[0002] Amaranthaceae plants are widely used in traditional Chinese medicine, and the pharmacopoeia clearly records: Cockscomb, which is the dried inflorescence of the Amaranthaceae plant Cockscomb (Cetera cristoto L.), is harvested when the flowers are in full bloom in autumn and dried in the sun. It is sweet, astringent and cool in nature and flavor, and enters the liver and large intestine meridians. It has the effects of astringent hemostasis, leucorrhea and analgesia, and is used for vomiting blood, metrorrhagia, blood in stool, hemorrhoidal bleeding, leucorrhea and chronic pain; Celosia argentea seeds, which are the dried mature seeds of the Amaranthaceae plant Celosia argentea (Celosia argentea L.). When the fruits are ripe in autumn, the plants are harvested or the fruit ears are picked, dried in the sun, the seeds are collected, and impurities are removed. It is bitter and slightly cold in nature and flavor, and enters the liver meridian. It has the effects of clearing the liver and purging fire, improving eyesight and removing cataracts. It is used for red eyes due to liver heat, cataracts in the eyes, blurred vision, and dizziness due to liver fire. Researching and constructing characteristic maps of Amaranthaceae Chinese medicinal materials is conducive to fully understanding the chemical composition of traditional Chinese medicine and providing a theoretical basis for its clinical use.

[0003] The first record of cockscomb as a medicine was in the Southern Yunnan Materia Medica: "Cockscomb can stop bleeding due to intestinal wind, uterine bleeding, and dysentery in women". The Ming Dynasty's "Essentials of Imperial Materia Medica", "Compendium of Materia Medica", and "Original Materia Medica" have descriptions of the original plant morphology of cockscomb, which is consistent with the description in the current "Chinese Medicinal Plants". Celosia chinensis, which is a plant of the Amaranthaceae family like cockscomb, has a plant morphology very similar to cockscomb. Most people are confused about cockscomb and Celosia chinensis. For example, in Taizhou and Qingjiang, Jiangsu, the inflorescence of Celosia chinensis is used as cockscomb. According to Compendium of Materia Medica, "Amaranthus grows in the fields. The young grass is edible and resembles Amaranth. The tall ones are three or four feet tall. The seedlings, leaves, flowers and fruits are the same as those of Cockscomb. However, the spikes of Cockscomb can be large and flat or round. In these, flower spikes emerge from the tips, with the tip four or five inches long, shaped like a rabbit's tail, water red, and some are yellowish and white. The seeds are in the spikes, and are as difficult to distinguish as Cockscomb and Amaranth. Su Gong's statement that they have horns is wrong." This shows that Amaranthus and Cockscomb are different medicinal materials and should be distinguished.

[0004] Chinese herbal medicines generally refer to clean herbal medicines and Chinese herbal medicine slices made by further cutting and roasting clean herbal medicines. Chinese herbal medicine slices are important medicinal substances for the clinical efficacy of traditional Chinese medicine. Their safety and effectiveness have been widely recognized, and their common use is mainly in the form of decoctions. Chinese herbal formula granules are granules made by extracting, separating, concentrating, drying, and granulating single herbal medicine slices through water heating. They have lost the identification characteristics of clean herbal medicines and slices, and can no longer be inspected and identified from the original shape, color, texture, cross-section, smell and other properties of the medicinal materials. In order to enable Chinese herbal formula granules to carry the safety and effectiveness of Chinese herbal medicine slices, standard decoctions are needed as a bridge. The standard decoction is a material benchmark for measuring whether the single-herbal Chinese herbal formula granules are basically consistent with the corresponding single-herbal Chinese herbal medicine slice clinical decoction. The "standard" in the standard decoction mainly covers the authenticity of the Chinese herbal medicine slices, the uniformity of the extraction process, and the rigor of quality control.

[0005] There is a report recording a detection method for Celosia cristata medicinal material, which uses kaempferol as a reference substance and acetonitrile-0.2% phosphoric acid solution (containing 0.2% triethylamine) as a mobile phase for liquid chromatography analysis to construct a characteristic spectrum of Celosia cristata medicinal material. This method uses hydrochloric acid hydrolysis in the preparation of the test solution. The resulting characteristic spectrum chromatogram is the compound information after acid hydrolysis, which cannot reflect the compound information of the sample itself. There is a lack of research on the prototype components of the compounds, and it is not enough to fully reflect the quality characteristics of Celosia cristata.

[0006] There is a report recording a quality control method for Celosia scomb, which uses luteolin, quercetin, and kaempferol as reference substances, and uses acetonitrile-0.1% phosphoric acid solution as the mobile phase for liquid chromatography analysis to construct an HPLC characteristic spectrum of Celosia scomb medicinal material. This method is time-consuming, and the separation between characteristic peaks is low, and the baseline is unstable, making it difficult to accurately measure the quality of Celosia scomb.

[0007] In view of this, the technical content of this application is specially proposed. Summary of the invention

[0008] Based on this, one of the purposes of the present application is to provide a method for constructing a characteristic spectrum of Amaranthaceae Chinese medicinal materials or their preparations, which method has a short detection time, good characteristic peak separation, and can quickly and comprehensively reflect the chemical characteristics of the test sample; another purpose of the present application is to provide a method for identifying Amaranthaceae Chinese medicinal materials or their preparations, and is suitable for the detection and identification of Celosia roxburghii medicinal materials, Celosia roxburghii standard decoction, Celosia roxburghii Chinese medicinal formula granules, Amaranthus aurantium medicinal materials, Amaranthus aurantium standard decoction, Amaranthus aurantium Chinese medicinal formula granules, etc.

[0009] The following is a detailed description of the technical solution of this application:

[0010] A method for constructing a characteristic spectrum of an Amaranthaceae Chinese medicinal material or its preparation comprises the following steps:

[0011] Take the standard sample of ferulic acid, add solvent to dissolve it, and prepare the reference solution.

[0012] Take a test sample, add an extraction solvent to extract, and prepare a test sample solution, wherein the test sample is selected from a Chinese medicinal material of the Amaranthaceae family or a preparation thereof,

[0013] The reference solution and the test solution are subjected to high performance liquid chromatography analysis.

[0014] Wherein, the conditions of the HPLC analysis include:

[0015] Gradient elution was performed using methanol as mobile phase A and a phosphoric acid aqueous solution with a volume concentration of 0.08-0.12% as mobile phase B. The procedure of the gradient elution included:

[0016] 0-7min, the volume percentage of the mobile phase A is maintained at 20%,

[0017] 7min~20min, the volume percentage of the mobile phase A increases from 20% to 24%,

[0018] 20min~30min, the volume percentage of the mobile phase A increases from 24% to 28%,

[0019] 30min to 50min, the volume percentage of the mobile phase A increases from 28% to 43%,

[0020] 50min~53min, the volume percentage of the mobile phase A is maintained at 43%,

[0021] From 53min to 58min, the volume percentage of the mobile phase A increased from 43% to 65%.

[0022] A method for identifying Amaranthaceae Chinese medicinal materials or their preparations, comprising the following steps:

[0023] Take a Chinese herbal medicine of Amaranthaceae or its preparation, and construct the characteristic spectrum of the standard product according to the characteristic spectrum construction method described in any of the above technical solutions,

[0024] Take the sample to be tested, add an extraction solvent to extract it, and prepare a sample solution, wherein the sample to be tested is selected from Amaranthaceae Chinese medicinal materials or preparations thereof,

[0025] The sample solution is subjected to high performance liquid chromatography analysis to obtain a characteristic spectrum of the sample.

[0026] Comparing the characteristic spectrum of the standard substance with the characteristic spectrum of the substance to be tested,

[0027] Wherein, the conditions of the HPLC analysis include:

[0028] Gradient elution was performed using methanol as mobile phase A and 0.08-0.12% volume concentration of phosphoric acid aqueous solution as mobile phase B.

[0029] The procedure of the gradient elution includes:

[0030] 0-7min, the volume percentage of the mobile phase A is maintained at 20%,

[0031] 7min~20min, the volume percentage of the mobile phase A increases from 20% to 24%,

[0032] 20min~30min, the volume percentage of the mobile phase A increases from 24% to 28%,

[0033] 30min to 50min, the volume percentage of the mobile phase A increases from 28% to 43%,

[0034] 50min~53min, the volume percentage of the mobile phase A is maintained at 43%,

[0035] From 53min to 58min, the volume percentage of the mobile phase A increased from 43% to 65%. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] In order to more clearly illustrate the specific implementation methods of the present application or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.

[0037] Figure 1 This is the full-wave scanning profile of the standard decoction of Celosia cristata in Example 1 ( Figure 1 A) and 3D spectrogram ( Figure 1 Middle B);

[0038] Figure 2 This is a comparison chart of the chromatographic results of the standard decoction of Celosia cristata in Example 1 under different detection wavelength conditions;

[0039] Figure 3 This is a comparison chart of the chromatographic results of the standard decoction of Celosia cristata in Example 1 under different gradient elution conditions;

[0040] Figure 4 This is a comparison chart of the chromatographic results of Celosia cristata medicinal material under different extraction solvent conditions in Example 2;

[0041] Figure 5 This is a comparison chart of the chromatographic results of Celosia cristata medicinal material under different extraction methods in Example 2;

[0042] Figure 6 This is a comparison chart of the chromatographic results of Celosia cristata medicinal material at different extraction times in Example 2;

[0043] Figure 7 This is a comparison chart of the chromatographic results of the specificity investigation of the Celosia cristata medicinal material in Example 3;

[0044] Figure 8 This is a comparison chart of the chromatographic results of the intermediate precision study of Celosia cristata medicinal material in Example 3;

[0045] Fig. 9 This is a comparison chart of the chromatographic results of the durability study of the Celosia cristata medicinal material under different column temperature conditions in Example 3;

[0046] Fig.10 This is a comparison chart of the chromatographic results of the Celosia cristata medicinal material under different flow rate conditions in the durability study in Example 3;

[0047] Fig.11 This is a comparison chart of the chromatographic results of the Celosia cristata medicinal material under different chromatographic column conditions in the durability study of the Celosia cristata medicinal material in Example 3;

[0048] Fig.12 This is a comparison chart of the chromatographic results of the Celosia cristata medicinal material under different chromatograph conditions in the durability study in Example 3;

[0049] Fig.13 The superimposed chromatograms of 16 batches of Celosia cristata medicinal materials in Example 4;

[0050] Fig.14 This is the reference characteristic spectrum of the Celosia cristata medicinal material used for reference in Example 4;

[0051] Fig.15 The superimposed chromatograms of 16 batches of Celosia cristata standard decoction in Example 4;

[0052] Fig.16 The reference characteristic spectrum of the standard decoction of Celosia cristata used for reference in Example 4;

[0053] Fig.17 The superimposed chromatograms of three batches of Celosia cristata Chinese medicine granules in Example 4;

[0054] Fig.18 The reference characteristic spectrum of the Celosia cristata Chinese medicine formula granules used for reference in Example 4;

[0055] Fig.19 The superimposed chromatograms of 5 batches of Amaranthus chinensis flower medicinal materials in Example 4;

[0056] Fig. 20 is the control characteristic spectrum of the Amaranthus chinensis flower medicinal material used for control in Example 4;

[0057] Fig.21 The chromatograms are superimposed for the five batches of standard decoctions of Amaranthus chinensis flowers in Example 4;

[0058] Fig. 22 is the control characteristic spectrum of the standard decoction of Amaranthus aurantifolia flowers used for control in Example 4;

[0059] Fig.23 This is a comparison diagram of the characteristic spectra of the medicinal material Celosia cristata and the medicinal material Amaranthus chinensis in Example 4;

[0060] Fig.24 This is a comparison diagram of the characteristic spectra of the standard decoction of Celosia cristata and the standard decoction of Amaranthus chinensis in Example 4;

[0061] Fig.25 This is the superimposed chromatogram of the Celosia cristata medicinal material prepared according to method 1 in comparative example 1 ( Fig.25 JGH09, JGH13, JGH14) and the comparison chart ( Fig.25 Middle R);

[0062] Fig.26 This is the superimposed chromatogram of the Celosia cristata medicinal material prepared according to method 2 in comparative example 1 ( Fig.26 JGH09, JGH13, JGH14) and the comparison chart ( Fig.26 Middle R);

[0063] Fig. 27 This is the superimposed chromatogram of the Celosia cristata medicinal material prepared according to method 3 in comparative example 1 ( Fig. 27 JGH09, JGH13, JGH14) and the comparison chart ( Fig. 27 Middle R);

[0064] Fig.28 It is a comparison chart of the characteristic spectrum of the Celosia cristata medicinal material prepared in Example 4 and the characteristic spectrum of the Celosia cristata medicinal material prepared by methods 1 to 3 of Comparative Example 1. DETAILED DESCRIPTION

[0065] The present application will be further described below in conjunction with the embodiments, examples and accompanying drawings. It should be understood that these examples are only used to illustrate the present application and are not intended to limit the scope of the present application. In addition, it should be understood that after reading the content taught in the present application, those skilled in the art may make various changes or modifications to the present application, and these equivalent forms also fall within the scope of protection of the claims attached to the present application.

[0066] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art to which this application belongs. The terms used herein in the specification of this application are only for the purpose of describing specific embodiments and are not intended to limit this application.

[0067] the term

[0068] Unless otherwise specified or incompatible herewith, the terms and phrases used herein shall have the following meanings:

[0069] The terms "and / or", "or / and", and "and / or" used in this article have a selection scope that includes any one of two or more related listed items, and also includes any and all combinations of the related listed items, said any and all combinations including any two related listed items, any more related listed items, or a combination of all related listed items.

[0070] Herein, "preferred", "preferable", "better", etc. are only used to describe implementation methods or examples with better effects. It should be understood that they do not constitute limitations on the scope of protection of this application.

[0071] In the present application, "further", "further", "particularly" and the like are used for descriptive purposes to indicate differences in content, but should not be construed as limiting the scope of protection of the present application.

[0072] In the present application, the technical features described in an open manner include closed technical solutions composed of the listed features, and also include open technical solutions containing the listed features.

[0073] In the present application, when it comes to numerical intervals (i.e., numerical ranges), unless otherwise specified, the optional numerical distribution is considered continuous within the above numerical interval, and includes the two numerical endpoints (i.e., the minimum and maximum values) of the numerical range, and each numerical value between the two numerical endpoints. Unless otherwise specified, when the numerical interval only refers to integers within the numerical interval, it includes the two endpoint integers of the numerical range, and each integer between the two endpoints. In addition, when multiple ranges are provided to describe features or characteristics, these ranges can be combined. In other words, unless otherwise specified, the ranges disclosed herein should be understood to include any and all subranges included therein.

[0074] The temperature parameters in this application, unless otherwise specified, are allowed to be either constant temperature treatment or to vary within a certain temperature range. It should be understood that the constant temperature treatment allows the temperature to fluctuate within the accuracy range controlled by the instrument. Fluctuations within the range of ±0.5°C, ±0.4°C, ±0.3°C, ±0.2°C, and ±0.1°C are allowed.

[0075] In the present application, weight may be μg, mg, g, kg or other mass units known in the chemical industry.

[0076] In one aspect of the present application, a method for constructing a characteristic spectrum of Amaranthaceae Chinese medicinal materials or their preparations is provided. The method can more quickly and comprehensively reflect the chemical characteristics of the test sample, and the separation of the characteristic peaks in the characteristic spectrum is good, the baseline is stable, the detection time is short, the method is reliable, and the three requirements of characteristic, reproducibility and operability are met.

[0077] In one embodiment, a method for constructing a characteristic spectrum of a Chinese medicinal material of Amaranthaceae or a preparation thereof comprises the following steps:

[0078] S100: Take a reference substance of ferulic acid, add a solvent to dissolve it, and prepare a reference substance solution.

[0079] S200: taking a test sample, adding an extraction solvent for extraction, and preparing a test sample solution, wherein the test sample is selected from a Chinese medicinal material of the Amaranthaceae family or a preparation thereof,

[0080] S300: Take the reference solution and the test solution for HPLC analysis.

[0081] Among them, the conditions for high performance liquid chromatography analysis include:

[0082] Gradient elution was performed using methanol as mobile phase A and a phosphoric acid aqueous solution with a volume concentration of 0.08-0.12% as mobile phase B. The procedure of gradient elution included:

[0083] 0-7min, the volume percentage of the mobile phase A is maintained at 20%,

[0084] 7min~20min, the volume percentage of the mobile phase A increases from 20% to 24%,

[0085] 20min~30min, the volume percentage of the mobile phase A increases from 24% to 28%,

[0086] 30min to 50min, the volume percentage of the mobile phase A increases from 28% to 43%,

[0087] 50min~53min, the volume percentage of the mobile phase A is maintained at 43%,

[0088] From 53min to 58min, the volume percentage of the mobile phase A increased from 43% to 65%.

[0089] Step S100: preparing a reference solution:

[0090] The reference substance used as a reference is often the main component of the test sample or a common peak with a relatively large peak area and stability. At present, kaempferol, luteolin, quercetin, kaempferol, etc. are often used as reference substances in the chromatographic analysis of Amaranthaceae plants or medicinal materials. During the development of the atlas construction method, the researchers of this application found that one of the main components of Celosia is ferulic acid, which has a hemostatic pharmacological effect and is the key effective ingredient for Celosia to exert its astringent and hemostatic effect, so ferulic acid was selected as a reference substance.

[0091] In one embodiment, an appropriate amount of ferulic acid reference substance is taken, accurately weighed, and methanol is added to prepare a solution containing 5 μg per 1 ml, which is used as a reference substance solution.

[0092] Step S200: preparing a test solution:

[0093] In step S200, the sample is extracted with an extraction solvent to obtain a sample solution, and the sample is selected from Amaranthaceae Chinese medicinal materials or preparations thereof.

[0094] In order to ensure that the main chemical components or active ingredients in the test sample are reflected in the characteristic spectrum, it is preferred to use an aqueous solution of alcohol as the extraction solvent.

[0095] In one embodiment, the extraction solvent is an alcohol-water mixture in which the volume percentage of alcohol is 60% to 80%; further, the alcohol is methanol.

[0096] In one embodiment, the extraction method is ultrasound; further, the power of ultrasound can be 200W to 400W, and the frequency of ultrasound can be 30kHz to 50kHz; further, the power of ultrasound can be 300W, and the frequency of ultrasound can be 40kHz.

[0097] In one embodiment, the extraction method is heating reflux. In the present application, heating reflux refers to heating at the boiling point ±5°C of the extraction solvent used.

[0098] In one embodiment, the extraction time is 20 to 40 min, and can further be 25 to 35 min, for example 20 min, 25 min, 30 min, 35 min, 40 min, etc.

[0099] In one embodiment, the test solution is prepared by the following steps: taking the test sample, adding the extraction solvent to perform a first extraction, performing solid-liquid separation to obtain a first liquid, evaporating the first liquid, adding the extraction solvent to perform a second extraction, and performing solid-liquid separation to obtain a second liquid. Optionally, the solid-liquid separation method is centrifugation and / or filtration.

[0100] In one embodiment, in step S200, the test sample is cockscomb medicinal material, about 2.0 g of cockscomb medicinal material powder (passed through No. 3 sieve) is taken, placed in a stoppered conical bottle, 50 ml of 70% methanol is added, ultrasonic treatment (power 300 W, frequency 40 kHz) is performed for 30 minutes, centrifuged, 25 ml of the supernatant is taken, evaporated to dryness, 70% methanol is added to the residue to make up to 10 ml volumetric flask, shaken well, filtered, and the filtrate is taken to obtain.

[0101] In one embodiment, in step S200, the test sample is the medicinal material of Celosia argentea. About 2.0 g of the medicinal material of Celosia argentea (passed through a No. 3 sieve) is taken and placed in a stoppered conical bottle. 50 ml of 70% methanol is added, and ultrasonic treatment (power 300 W, frequency 40 kHz) is performed for 30 minutes. Centrifugation is performed, 25 ml of the supernatant is taken, evaporated to dryness, and 70% methanol is added to the residue to make up the volume to a 10 ml volumetric flask. The residue is shaken, filtered, and the filtrate is taken to obtain the product.

[0102] In one embodiment, in step S200, the test sample is a standard decoction of cockscomb, and an appropriate amount of the standard decoction of cockscomb is taken, ground into powder, and about 0.5 g is taken and placed in a stoppered conical flask, and 25 ml of 70% methanol is added, and ultrasonic treatment (power 300 W, frequency 40 kHz) is performed for 30 minutes, and centrifuged. 20 ml of the supernatant is taken and evaporated to dryness, and 70% methanol is added to the residue to make up the volume to a 10 ml volumetric flask, shaken well, filtered, and the filtrate is taken to obtain the product.

[0103] In one of the embodiments, in step S200, the test sample is cockscomb Chinese medicine formula granules, take an appropriate amount of cockscomb Chinese medicine formula granules, grind them into powder, take about 0.5 g, put them in a stoppered conical bottle, add 25 ml of 70% methanol, ultrasonically treat (power 300 W, frequency 40 kHz) for 30 minutes, centrifuge, take 20 ml of the supernatant, evaporate to dryness, add 70% methanol to the residue and make up to 10 ml volumetric flask, shake well, filter, and take the filtrate to obtain.

[0104] In one embodiment, in step S200, the test sample is a standard decoction of Amaranthus aurantifolia flowers. An appropriate amount of the standard decoction of Amaranthus aurantifolia flowers is taken, ground into powder, and about 0.5 g is taken and placed in a stoppered conical flask. 25 ml of 70% methanol is added, and ultrasonic treatment (power 300 W, frequency 40 kHz) is performed for 30 minutes. The supernatant is centrifuged and 20 ml is taken and evaporated to dryness. The residue is diluted with 70% methanol to a 10 ml volumetric flask, shaken, filtered, and the filtrate is taken to obtain the product.

[0105] Step S300 High Performance Liquid Chromatography Analysis:

[0106] In step S300, by establishing appropriate chromatographic conditions, analysis time can be saved, analysis efficiency can be improved, and characteristic peaks with good peak separation and appropriate response values ​​can be obtained.

[0107] In one embodiment, gradient elution is performed using methanol as mobile phase A and a phosphoric acid aqueous solution with a volume concentration of 0.08-0.12% as mobile phase B. Furthermore, the mobile phase B is a phosphoric acid solution with a volume concentration of 0.1%.

[0108] In one embodiment, the gradient elution procedure comprises:

[0109] 0-7min, the volume percentage of the mobile phase A is maintained at 20%,

[0110] 7min~20min, the volume percentage of the mobile phase A increases from 20% to 24%,

[0111] 20min~30min, the volume percentage of the mobile phase A increases from 24% to 28%,

[0112] 30min to 50min, the volume percentage of the mobile phase A increases from 28% to 43%,

[0113] 50min~53min, the volume percentage of the mobile phase A is maintained at 43%,

[0114] From 53min to 58min, the volume percentage of the mobile phase A increased from 43% to 65%.

[0115] In one embodiment, the detection wavelength of the HPLC analysis is 280 nm to 290 nm, and can further be 286 nm.

[0116] In one embodiment, the column temperature of the HPLC analysis is 35°C to 45°C, and can further be 40°C.

[0117] In one embodiment, the flow rate of the HPLC analysis is 0.25 mL / min to 0.35 mL / min, and can further be 0.3 mL / min.

[0118] In one embodiment, the injection volume of the HPLC analysis is 1 μL to 3 μL, and can further be 2 μL.

[0119] In one embodiment, the chromatographic column for high performance liquid chromatography analysis uses octadecylsilane bonded silica gel as a filler. Further, the inner diameter of the chromatographic column is 2 mm to 2.2 mm, the column length is 140 mm to 160 mm, and the particle size is 1.7 μm to 1.9 μm.

[0120] In one of the embodiments, the theoretical plate number of the HPLC analysis is not less than 5000, calculated based on the ferulic acid peak.

[0121] In another aspect of the present application, it relates to a method for identifying Amaranthaceae Chinese medicinal materials or preparations thereof, the identification method comprises the following steps: subjecting an analyte to high performance liquid chromatography analysis to obtain a characteristic spectrum of the analyte, and comparing the characteristic spectrum of the analyte with the characteristic spectrum of a standard sample of Amaranthaceae Chinese medicinal materials or preparations thereof, thereby identifying the type and quality of the analyte.

[0122] In one embodiment, the method for identifying the Amaranthaceae Chinese medicinal material or its preparation comprises the following steps:

[0123] S010: Take a Chinese herbal medicine of Amaranthaceae or its preparation, and construct a characteristic spectrum of the standard product according to the characteristic spectrum construction method described in any of the above technical solutions,

[0124] S020: Take the sample to be tested, add an extraction solvent to extract, and prepare a solution of the sample to be tested, wherein the sample to be tested is selected from a Chinese medicinal material of the Amaranthaceae family or a preparation thereof,

[0125] S030: Take the solution of the test product and conduct high performance liquid chromatography analysis to obtain the characteristic spectrum of the test product.

[0126] S040: Compare the characteristic spectrum of the standard product with the characteristic spectrum of the product to be tested.

[0127] Among them, the conditions for high performance liquid chromatography analysis include:

[0128] Gradient elution was performed using methanol as mobile phase A and 0.08-0.12% volume concentration of phosphoric acid aqueous solution as mobile phase B.

[0129] The gradient elution procedure includes:

[0130] 0~7min, the volume percentage of mobile phase A is maintained at 20%,

[0131] From 7min to 20min, the volume percentage of mobile phase A increased from 20% to 24%.

[0132] From 20min to 30min, the volume percentage of mobile phase A increased from 24% to 28%.

[0133] From 30min to 50min, the volume percentage of mobile phase A increased from 28% to 43%.

[0134] 50min~53min, the volume percentage of mobile phase A is maintained at 43%,

[0135] From 53min to 58min, the volume percentage of mobile phase A increased from 43% to 65%.

[0136] It can be understood that the high performance liquid chromatography analysis process in the identification method of the present application is similar to the high performance liquid chromatography analysis process of the characteristic spectrum construction method described in any of the above technical solutions, wherein the preparation of the test solution is the same as the preparation of the test solution described in any of the above technical solutions, which will not be repeated here.

[0137] It can be understood that the spectrum of the analyte and the characteristic spectrum of the standard substance constructed in the identification method of the present application can be used for direct comparison, or data analysis can be performed as needed. For example, a single analyte is tested and compared with the characteristic spectrum of different standard substances to obtain the attribution, authenticity, or quality test results of the single analyte; or multiple batches of analytes are tested, and the characteristic spectrum of multiple batches of analytes is compared with each other, and the common features between the multiple batches of analytes are extracted with or without data analysis.

[0138] The following are some specific embodiments.

[0139] The following are the instruments, reagents and reagents used in the specific examples:

[0140] Instruments: Waters ultra-high performance liquid chromatograph (Waters H-Class, Waters Technology (China) Co., Ltd.), Agilent high performance liquid chromatograph (1290, Agilent), Thermo Fisher ultra-high performance liquid chromatograph (Themo Vanquish, Thermo Fisher), Waters HSS T3 chromatographic column (2.1 mm × 150 mm, 1.8 μm), Agilent ZORBAX SB-C18 (2.1 mm × 150 mm, 1.8 μm); one-tenth balance (ME204E, Mettler-Toledo), one-millionth balance (XP26, Mettler-Toledo), constant temperature water bath (HWS28, Shanghai Yiheng Technology Co., Ltd.), ultrapure water system (Milli-QDirect, Merck & Co., Ltd.).

[0141] Reagents: ethanol (Xilong Scientific Co., Ltd.), methanol (Xilong Scientific Co., Ltd.), and hydrochloric acid (Xilong Scientific Co., Ltd.) were of analytical grade; phosphoric acid (Tianjin Komiou Chemical Reagent Co., Ltd.), acetonitrile (Merck Co., Ltd.), and methanol (Merck Co., Ltd.) for liquid phase were of HPLC grade; water was ultrapure water (self-made in the laboratory).

[0142] Test drugs: ferulic acid (batch number: 110773-201915; content: 99.4%; source: China Food and Drug Inspection Institute), p-hydroxycinnamic acid (batch number: 21101401; content: 99.94%; source: Chengdu Greep Biotechnology Co., Ltd.), tryptophan (batch number: 140686-201904; content: 99.9%; source: China Food and Drug Inspection Institute).

[0143] The 2020 edition of the Chinese Pharmacopoeia stipulates that cockscomb is the dried inflorescence of Celosia cristata L., a plant of the Amaranthaceae family. The medicinal materials used in this study have been identified by the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences. The specific information is shown in Table 1. The information of the Celosia cristata flower samples is shown in Table 2.

[0144] Table 1 Celosia scomb medicinal material origin information

[0145]

[0146]

[0147] Table 2 Information on the origin of the medicinal material Coptidis chinensis

[0148]

[0149] Example 1

[0150] In this example, the chromatographic conditions for the characteristic spectrum construction method were established, taking into account the absorption wavelength and elution gradient.

[0151] 1.1 Determination of absorption wavelength

[0152] Take an appropriate amount of cockscomb standard decoction, grind it into powder, take about 0.5g, weigh it accurately, put it in a stoppered conical flask, accurately add 25ml of 70% methanol, weigh it, treat it ultrasonically (power 300W, frequency 40kHz) for 30 minutes, weigh it again, make up the lost weight with 70% methanol, shake it well, centrifuge it, take 20ml, evaporate it to dryness, make up the volume to 10ml with 70% methanol, shake it well, filter it, and take the filtrate to obtain it.

[0153] Chromatographic conditions: Waters HSS T3 chromatographic column (2.1 mm×150 mm, 1.8 μm); methanol as mobile phase A, 0.1% phosphoric acid solution as mobile phase B, gradient elution as specified in Table 3; flow rate of 0.30 ml per minute; column temperature of 40°C.

[0154] Table 3 Gradient elution table

[0155]

[0156] Test results such as Figure 1-2 ,according to Figure 1-2 It can be found that when 285nm is selected as the detection wavelength, there is more chromatographic peak information, so 285m is selected as the detection wavelength of the characteristic spectrum of Celosia cristata.

[0157] 1.2 Establishment of elution conditions

[0158] A Waters HSS T3 chromatographic column (2.1 mm×150 mm, 1.8 μm) was used; methanol was used as mobile phase A, 0.1% phosphoric acid solution was used as mobile phase B, and gradient elution was performed according to the provisions of Table 4.

[0159] Table 4 Gradient elution table

[0160]

[0161]

[0162] Test results such as Figure 3 ,according to Figure 3 Different elution gradients have a significant effect on the separation of the chromatographic peaks of the characteristic spectrum of Celosia cristata. When using condition 8, the separation of the chromatographic peaks is better and the distribution of the chromatographic peaks is more uniform. Therefore, the chromatographic conditions are determined as follows: Waters HSS T3 chromatographic column (2.1mm×150mm, 1.8μm); methanol as mobile phase A, 0.1% phosphoric acid as mobile phase B, gradient elution according to condition 8; flow rate of 0.30ml per minute; column temperature of 40℃; detection wavelength of 285nm; injection volume of 2μl.

[0163] Example 2

[0164] In this example, the preparation method of the test solution is studied. Through single factor analysis, the effects of extraction solvent, extraction method and extraction time on the characteristic spectrum of Celosia cristata medicinal material are investigated to determine the optimal sample pretreatment method.

[0165] 2.1 Investigation of extraction solvent

[0166] The effects of different extraction solvents on the characteristic spectrum of Celosia cristata medicinal materials were investigated respectively. Methanol, 70% methanol, 50% methanol, 30% methanol, ethanol, 70% ethanol, 50% ethanol and 30% ethanol were used as extraction solvents. The peak shape and separation of 9 characteristic peaks consistent with the retention time of the characteristic peaks of the standard decoction were observed, and the "total peak area / sample weight" of the 9 characteristic peaks was calculated to compare the effects of different extraction solvents on the characteristic spectrum of Celosia cristata medicinal materials, and the optimal extraction solvent was selected.

[0167] Take about 2.0g of cockscomb medicinal powder (passed through No. 3 sieve, batch number: JGH06), accurately weigh, and place in 8 parallel groups, 2 portions in each group, in a stoppered conical bottle, accurately add methanol, 70% methanol, 50% methanol, 30% methanol, ethanol, 70% ethanol, 50% ethanol, 30% ethanol 50ml, weigh, ultrasonic treatment (power 300W, frequency 40kHz) for 30 minutes, cool, weigh again, make up the lost weight with the corresponding solvent, shake well, centrifuge, take 25ml, evaporate to dryness, make up to 10ml with the corresponding solvent, filter, and take the filtrate for sampling and determination. The results of the investigation of different extraction solvents for the characteristic spectrum of cockscomb medicinal materials are shown in Table 5. Figure 4 .

[0168] Table 5 Results of investigation on different extraction solvents for characteristic spectrum of Celosia cristata

[0169]

[0170] The results showed that the extraction effects of 8 extraction solvents were compared by "total characteristic peak area / sample weight". The results showed that 70% methanol had a better extraction effect and a better peak shape, so 70% methanol was selected as the extraction solvent.

[0171] 2.2 Investigation of extraction methods

[0172] This experiment investigated the effects of different extraction methods on the characteristic spectrum of Celosia cristata medicinal materials. Ultrasonic treatment and heating reflux were selected as extraction methods. The characteristic spectrum results of different extraction methods were compared through the temporarily determined total peak area / sample weight of 9 chromatographic peaks and chromatograms.

[0173] Take about 2.0g of cockscomb powder (passed through No. 3 sieve, batch number: JGH06), accurately weigh, a total of 2 groups, 2 portions in each group, place in a stoppered conical bottle, accurately add 50ml of 70% ethanol each, weigh the weight, heat and reflux for 30 minutes, ultrasonic treatment (power 300W, frequency 40kHz) for 30 minutes, cool, weigh again, make up the lost weight with 70% methanol, shake well, centrifuge, take 25ml, evaporate to dryness, make up to 10ml with 70% methanol, shake well, filter, take the filtrate for sampling and determination. The results of the investigation of different extraction methods of cockscomb medicinal material characteristic spectrum are shown in Table 6. Figure 5 .

[0174] Table 6 Results of investigation on different extraction methods of Celosia cristata medicinal material characteristic spectrum

[0175]

[0176] By comparing ultrasonic treatment and heating reflux extraction, it was found that different extraction methods had little effect on the characteristic spectrum of Celosia cristata medicinal materials. Considering the ease of operation, ultrasonic treatment was selected as the extraction method.

[0177] 2.3 Extraction time investigation

[0178] This experiment investigated the effects of different extraction times on the characteristic spectrum of Celosia cristata medicinal materials. Four different extraction times of 15 minutes, 30 minutes, 45 minutes and 60 minutes were selected for investigation. The characteristic spectrum results of different extraction times were compared through the temporarily determined 9 chromatographic peaks "total peak area / sample weight" and chromatograms.

[0179] Take about 2.0g of cockscomb powder (passed through No. 3 sieve, batch number: JGH06), accurately weigh, a total of 2 groups, 2 portions in each group, put in a stoppered conical bottle, accurately add 50ml of 70% methanol each, weigh the weight, ultrasonically treat (power 300W, frequency 40kHz) for 15 minutes, 30 minutes, 45 minutes, and 60 minutes respectively, let cool, weigh again, make up the lost weight with 70% methanol, shake well, centrifuge, take 25ml, evaporate to dryness, make up to 10ml with 70% methanol, shake well, filter, and take the filtrate for sampling and determination. The results of the investigation of the characteristic spectrum of cockscomb medicinal materials at different extraction times are shown in Table 7. Figure 6 .

[0180] Table 7 Results of investigation on characteristic spectrum of Celosia cristata at different extraction times

[0181]

[0182] By comparing the effects of different extraction times on the characteristic spectra of the standard decoction of Cockscomb, it was found that different extraction times had little effect on the characteristic spectra of Cockscomb. In order to ensure complete extraction, the extraction time was selected as 30 minutes.

[0183] 2.4 Determination of the preparation method of the test solution

[0184] According to the above experimental results, the sample pretreatment method of the characteristic spectrum of Celosia scomb medicinal material can be determined as follows: take about 2.0g of Celosia scomb medicinal material powder (passed through No. 3 sieve), accurately weigh it, put it in a stoppered conical bottle, add 25ml of 70% methanol, ultrasonically treat it (power 300W, frequency 40kHz) for 30 minutes, cool it, weigh it again, make up the lost weight with 70% methanol, centrifuge it, take 25ml of the supernatant, evaporate it to dryness, add 70% methanol to make up the volume to a 10ml volumetric flask, shake it well, filter it, and take the filtrate.

[0185] Take about 2.0g of Celosia argentea flower powder (passed through No. 3 sieve), accurately weigh it, put it in a stoppered conical bottle, add 25ml of 70% methanol, ultrasonically treat (power 300W, frequency 40kHz) for 30 minutes, let cool, weigh it again, make up the lost weight with 70% methanol, centrifuge, take 25ml of the supernatant, evaporate to dryness, add 70% methanol to make up to the volume in a 10ml volumetric flask, shake well, filter, and take the filtrate.

[0186] Example 3

[0187] This example is a methodological verification of the characteristic map construction method, and is examined from multiple dimensions such as specificity, precision, repeatability, stability, intermediate density, and durability.

[0188] 3.1 Exclusivity Investigation

[0189] Accurately pipette 2 μl of the test solution, reference solution and blank solvent of Celosia cristata (JGH06) and inject them into the liquid chromatograph for determination. Figure 7 .

[0190] The results showed that the test sample chromatogram had the same chromatographic peak at the corresponding retention time as the reference sample chromatogram, and there was no negative interference, indicating that the method had good specificity.

[0191] 3.2 Precision investigation

[0192] Take an appropriate amount of Celosia cristata (JGH06), grind it into powder, take about 2.0g, weigh it accurately, prepare the test solution according to the determined test solution preparation method, inject and analyze, inject the same test solution 6 times continuously, take the ferulic acid peak as the reference peak, calculate the relative retention time and relative peak area of ​​each characteristic peak and S peak, and calculate the RSD value. The experimental results are shown in Tables 8 and 9.

[0193] Table 8 Results of precision investigation of characteristic spectrum of Celosia cristata medicinal material (relative retention time)

[0194]

[0195] Table 9 Precision investigation results of characteristic spectrum of Celosia cristata medicinal materials (relative peak area)

[0196]

[0197] The results showed that the same sample solution was injected 6 times continuously, with the ferulic acid peak as the reference peak S. The relative retention time RSD values ​​of each characteristic peak and the S peak were in the range of 0.02% to 0.05%, and the relative peak area RSD values ​​were in the range of 0.27% to 1.56%. The RSD value was less than 5%, indicating that the instrument had good precision.

[0198] 3.3 Repeatability study

[0199] Take an appropriate amount of Celosia cristata (JGH06), grind it into powder, take about 2.0g, and weigh 6 parts in parallel. Prepare the test solution according to the determined test solution preparation method, inject and analyze, take the ferulic acid peak as the reference peak, calculate the relative retention time and relative peak area of ​​each characteristic peak and S peak, and calculate the RSD value. The experimental results are shown in Tables 10 and 11.

[0200] Table 10 Results of repeatability study of characteristic spectrum of Celosia cristata medicinal material (relative retention time)

[0201]

[0202]

[0203] Table 11 Results of repeatability study of characteristic spectrum of Celosia cristata medicinal material (relative peak area)

[0204]

[0205] The results showed that the same batch of samples were measured six times, with the ferulic acid chromatographic peak as the reference peak. The relative retention time RSD values ​​of each characteristic peak and the S peak were in the range of 0.01% to 0.09%, and the relative peak area RSD values ​​were in the range of 1.60% to 4.89%. The RSD value was less than 5%, indicating that the method had good repeatability.

[0206] 3.4 Stability investigation

[0207] Take an appropriate amount of Celosia cristata (JGH06), grind it into powder, take about 2.0g, weigh it accurately, prepare the test solution according to the determined test solution preparation method, inject and analyze at 0, 3, 7, 10, 14, and 24 hours, take the ferulic acid peak as the reference peak, calculate the relative retention time and relative peak area of ​​each characteristic peak and S peak, and calculate the RSD value. The experimental results are shown in Tables 12 and 13.

[0208] Table 12 Results of stability study of characteristic spectrum of Celosia cristata medicinal materials (relative retention time)

[0209]

[0210] Table 13 Results of stability study of characteristic spectrum of Celosia cristata medicinal materials (relative peak area)

[0211]

[0212] The experimental results showed that the RSD of the relative retention time and relative peak area of ​​each chromatographic peak within 24 hours was less than 5%, and the test solution was stable within 24 hours.

[0213] 3.5 Intermediate precision study

[0214] Different analysts operated on different instruments at different times. An appropriate amount of Celosia cristata (JGH06) was taken and ground. About 2.0 g was taken and 6 portions were accurately weighed. Six portions of test solution were prepared according to the determined test solution preparation method. The samples were injected and analyzed. The ferulic acid peak was used as the reference peak. The relative retention time and relative peak area of ​​each characteristic peak and the S peak were calculated, and the RSD value was calculated. The experimental results are shown in Tables 14 and 15, and the intermediate precision investigation chromatograms are shown in Figure 8 .

[0215] Table 14 Intermediate precision test results of Celosia cristata (relative retention time)

[0216]

[0217] Table 15 Intermediate precision investigation results of Celosia cristata medicinal materials (relative peak area)

[0218]

[0219] The results showed that the same batch of samples were measured 6 times by different analysts on different instruments at different times. Taking ferulic acid peak as reference peak S, the relative retention time RSD values ​​of each characteristic peak were in the range of 0.04% to 0.16%, the relative peak area RSD values ​​were in the range of 1.40% to 2.50%, the relative retention time and the RSD values ​​of 6 data of repeatability test were in the range of 0.13% to 1.50%, the relative peak area and the RSD values ​​of 6 data of repeatability test were in the range of 7.29% to 19.28%. The relative peak area RSD value was large because the sample response value was small. Therefore, the relative peak area limit of Celosia cristata is not specified for the time being.

[0220] 3.6 Durability test

[0221] 3.6.1 Investigation of different column temperatures

[0222] The effects of different column temperatures, namely 38℃, 40℃ and 42℃, on the characteristic spectrum of Celosia cristata were compared.

[0223] Take an appropriate amount of cockscomb (JGH06), grind it into powder, take about 2.0g, weigh it accurately, prepare the test solution according to the determined test solution preparation method, except that the column temperature is 38℃, 40℃ and 42℃ respectively, the other chromatographic conditions are the same as those specified under the chromatographic conditions, inject and analyze, take the ferulic acid peak as the reference peak, calculate the relative retention time and relative peak area of ​​each characteristic peak and S peak, and calculate the RSD value. The experimental results are shown in Table 16, Table 17, Fig. 9 .

[0224] Table 16 Column temperature investigation results of characteristic spectrum of Celosia cristata medicinal material (relative retention time)

[0225]

[0226] Table 17 Column temperature investigation results of Celosia cristata medicinal material characteristic spectrum (relative peak area)

[0227]

[0228] The experimental results show that at different column temperatures, the relative retention time RSD values ​​of each chromatographic peak are in the range of 0.18% to 2.75%, and the relative peak area RSD values ​​are in the range of 2.69% to 4.93%. The RSD values ​​are all less than 5%. The results show that the analytical method has good durability at different column temperatures. Small changes in column temperature can meet the system suitability requirements.

[0229] 3.6.2 Investigation of different flow rates

[0230] The effects of different flow rates, namely 0.28ml / min, 0.30ml / min and 0.32ml / min, on the characteristic spectrum of Celosia cristata were compared.

[0231] Take an appropriate amount of cockscomb (JGH06), grind it into powder, take about 2.0g, weigh it accurately, and prepare the test solution according to the determined test solution preparation method. Except that the flow rates are 0.28ml / min, 0.30ml / min and 0.32ml / min respectively, other chromatographic conditions are the same as those specified under the chromatographic conditions. Sample injection analysis, using ferulic acid peak as the reference peak, calculate the relative retention time and relative peak area of ​​each characteristic peak and S peak, and calculate the RSD value. The experimental results are shown in Tables 18, 19, Fig.10 .

[0232] Table 18 Flow rate investigation results of Celosia cristata medicinal material characteristic spectrum (relative retention time)

[0233]

[0234] Table 19 Flow rate investigation results of Celosia cristata medicinal material characteristic spectrum (relative peak area)

[0235]

[0236] The experimental results show that at different flow rates, the relative retention time RSD values ​​of each chromatographic peak are in the range of 0.76% to 4.05%, and the relative peak area RSD values ​​are in the range of 0.40% to 4.36%. The RSD values ​​are all less than 5%. The results show that the analytical method has good durability at different flow rates. Small changes in flow rate can meet the system suitability requirements.

[0237] 3.6.3 Investigation of different chromatographic columns

[0238] The effects of three Waters HSS T3 chromatographic columns (2.1 mm × 150 mm, 1.8 μm) on the durability of the characteristic spectrum of Celosia cristata were compared. The chromatographic columns were numbered BH-313, BH-317, and BH-318 respectively.

[0239] Take an appropriate amount of cockscomb (JGH06), grind it into powder, take about 2.0g, weigh it accurately, prepare the test solution according to the determined test solution preparation method, except for the different chromatographic columns, the other chromatographic conditions are the same as those specified under the chromatographic conditions, inject and analyze, take the ferulic acid peak as the reference peak S, calculate the relative retention time and relative peak area of ​​each characteristic peak and the S peak, and calculate the RSD value. The experimental results are shown in Table 20, Table 21, Fig.11 .

[0240] Table 20 Results of the chromatographic column investigation of the characteristic spectrum of Celosia cristata medicinal materials (relative retention time)

[0241]

[0242] Table 21 Results of the chromatographic column investigation of the characteristic spectrum of Celosia cristata medicinal materials (relative peak area)

[0243]

[0244] The experimental results show that the relative retention time RSD values ​​of each chromatographic peak are in the range of 0.10% to 1.53% when using chromatographic columns of the same brand but different batches; the relative peak area RSD values ​​are in the range of 7.92% to 12.65%. This indicates that the relative retention time of each characteristic peak has good durability, while the relative peak area is greatly affected by different batches of chromatographic columns. Therefore, the relative peak area range is not specified for the time being.

[0245] 3.6.4 Investigation of different chromatographs

[0246] Compare the effects of different chromatographs such as Waters, Agilent and Thermo on the durability of the characteristic spectrum of Celosia cristata.

[0247] Take an appropriate amount of Celosia cristata (JGH06), grind it into powder, take about 2.0 g, weigh it accurately, prepare the test solution according to the determined test solution preparation method, inject and analyze on Waters, Agilent, and Thermo chromatographs, respectively, take the ferulic acid peak as the reference peak S, calculate the relative retention time and relative peak area of ​​each characteristic peak and the S peak, and calculate the RSD value. The experimental results are shown in Table 23, Table 24, Fig.12 .

[0248] Table 22 Flow rate investigation results of Celosia cristata medicinal material characteristic spectrum (relative retention time)

[0249]

[0250] Table 23 Flow rate investigation results of Celosia cristata medicinal material characteristic spectrum (relative peak area)

[0251]

[0252] The experimental results show that the relative retention time RSD values ​​of each chromatographic peak are in the range of 0.07% to 1.81% when using different chromatographs; the relative peak area RSD values ​​are in the range of 12.28% to 28.93%. This shows that the relative retention time of each characteristic peak can meet the system suitability requirements, while the relative peak area is slightly affected by the chromatograph. Therefore, the relative peak area range is not specified for the time being.

[0253] 3.6.5 Durability Summary

[0254] The specificity and integrity of the characteristic spectrum analysis method of Celosia cristata were investigated, and the characteristic peaks were not interfered by solvent peaks; the precision, stability and repeatability were investigated, and the RSD of the relative retention time of each chromatographic peak was <5%, and the test solution was stable within 24 hours; the intermediate precision was investigated, and different analysts operated on different dates and different chromatographs, and the relative retention time of each chromatographic peak was within the range (±10%); the durability was investigated, and the relative retention time of each chromatographic peak was within the range (±10%) for different chromatographic columns, different flow rates and a small range of column temperature changes, which can meet the system adaptability requirements.

[0255] Example 4

[0256] This embodiment constructs characteristic spectra of cockscomb medicinal materials, cockscomb standard decoction, cockscomb formula granules, amaranth flower medicinal materials, and amaranth flower standard decoction, which specifically includes the following steps:

[0257] Step 1: Preparation of reference solution

[0258] Take an appropriate amount of ferulic acid reference substance, weigh it accurately, and add methanol to make a solution containing 5 μg per 1 ml, which serves as the reference substance solution.

[0259] Step 2: Preparation of test solution

[0260] Take about 2.0g of cockscomb powder (passed through No. 3 sieve), place it in a stoppered conical bottle, add 50ml of 70% methanol, ultrasonically treat (power 300W, frequency 40kHz) for 30 minutes, centrifuge, take 25ml of the supernatant, evaporate to dryness, add 70% methanol to the residue to make up to 10ml volumetric flask, shake well, filter, and take the filtrate to obtain.

[0261] Take about 2.0g of the powder of the medicinal material of Amaranthus chinensis (passed through a No. 3 sieve), place it in a stoppered conical flask, add 50ml of 70% methanol, ultrasonically treat (power 300W, frequency 40kHz) for 30 minutes, centrifuge, take 25ml of the supernatant, evaporate to dryness, add 70% methanol to the residue to make up to 10ml volumetric flask, shake well, filter, and take the filtrate to obtain the product.

[0262] Take an appropriate amount of cockscomb standard decoction, grind it into powder, take about 0.5g, put it in a stoppered conical bottle, add 25ml of 70% methanol, ultrasonically treat (power 300W, frequency 40kHz) for 30 minutes, centrifuge, take 20ml of the supernatant, evaporate to dryness, add 70% methanol to the residue to make up to 10ml volumetric flask, shake well, filter, and take the filtrate.

[0263] Take an appropriate amount of standard decoction of Amaranthus chinensis flower, grind it into powder, take about 0.5g, put it in a stoppered conical flask, add 25ml of 70% methanol, ultrasonically treat (power 300W, frequency 40kHz) for 30 minutes, centrifuge, take 20ml of the supernatant, evaporate to dryness, add 70% methanol to the residue to make up to 10ml volumetric flask, shake well, filter, and take the filtrate.

[0264] Take an appropriate amount of cockscomb formula granules, grind them into powder, take about 0.5g, put it in a stoppered conical flask, add 25ml of 70% methanol, ultrasonically treat (power 300W, frequency 40kHz) for 30 minutes, centrifuge, take 20ml of the supernatant, evaporate to dryness, add 70% methanol to the residue to make up to 10ml volumetric flask, shake well, filter, and take the filtrate.

[0265] Step 3: Sample measurement

[0266] Chromatographic conditions and system suitability test: octadecylsilane bonded silica gel is used as filler (column length is 150 mm, inner diameter is 2.1 mm, particle size is 1.8 μm); methanol is used as mobile phase A, 0.1% phosphoric acid solution is used as mobile phase B, and gradient elution is performed according to the provisions in Table 24; flow rate is 0.3 ml per minute; column temperature is 40°C; detection wavelength is 286 nm. The number of theoretical plates calculated based on the ferulic acid peak should not be less than 5000.

[0267] Table 24 Gradient elution table

[0268]

[0269] Accurately pipette 2 μl of reference solution and test solution respectively, inject into liquid chromatograph, and measure;

[0270] The "Chinese Herbal Medicine Chromatographic Characteristic Spectrum Similarity Evaluation Software" was used to generate chromatograms according to the average method (or median method), and the characteristic spectra of Celosia cristata and Celosia chinensis were established. Among them, 9 common peaks were determined for Celosia cristata medicinal materials, Celosia cristata standard decoction, and Celosia cristata formula granules, and 3 chromatographic peaks were identified, peak 1 was tryptophan, peak 2 was p-hydroxycinnamic acid, and peak 3 was ferulic acid; Celosia chinensis medicinal materials and Celosia chinensis standard decoction had 5 common peaks detected, which were consistent with peaks 1 to 4 and peak 8 in the Celosia cristata chromatogram. The chromatogram is shown in the figure below. Figure 13 to Figure 22 .

[0271] According to the analysis results, the common peaks of Celosia cristata include: peak 1, peak 2, peak 3, peak 4, peak 5, peak 6, peak 7, peak 8, peak 9; the peak corresponding to the ferulic acid reference is taken as the S peak, and the relative retention time of each characteristic peak and the S peak is calculated, and the relative retention time should be within ±10% of the specified value, and the specified value is: 0.24 (peak 1), 0.77 (peak 2), 1.21 (peak 4), 1.50 (peak 5), 1.55 (peak 6), 1.60 (peak 7), 2.13 (peak 8), 2.53 (peak 9);

[0272] The common peaks of Amaranthus chinensis flower include: peak 1, peak 2, peak 3, peak 4, and peak 8; the peak corresponding to the ferulic acid reference is taken as the S peak, and the relative retention time of each characteristic peak and the S peak is calculated, and the relative retention time should be within ±10% of the specified value, and the specified value is: 0.24 (peak 1), 0.77 (peak 2), 1.21 (peak 4), 2.13 (peak 8);

[0273] The characteristic spectrum of the obtained Celosia cristata medicinal material ( Fig.23 ) and the characteristic spectrum of the medicinal material of Amaranthus chinensis ( Fig.24 ) were compared and it was found that the characteristic spectrum of Celosia scomb was significantly different from that of Celosia scomb. Celosia scomb and Celosia scomb had 5 common peaks, among which Celosia scomb had unique peaks 5, 6, 7 and 9, which were not found in the characteristic spectrum of Celosia scomb. Therefore, the two could be distinguished by the characteristic peaks.

[0274] Comparative Example 1

[0275] Through literature research, it was found that some scholars have established the HPLC fingerprint of Celosia cristata, which is different from the present case study in terms of the preparation conditions of the test solution and the chromatographic conditions. The test sample in the literature is prepared by heating in an alcohol solution of hydrochloric acid or by extracting with 95% ethanol or water. The preparation method is as follows:

[0276] Method 1: Take about 0.2g of cockscomb powder (passed through No. 3 sieve), accurately weigh it, place it in a stoppered conical flask, accurately add 50ml of ethanol-water-hydrochloric acid (50:20:15) mixed solution, weigh the mass, heat and reflux for 60min, cool, weigh again, make up the lost mass with ethanol-water-hydrochloric acid (50:20:15) mixed solution, shake well, filter, and take the filtrate to obtain the product.

[0277] Method 2: Take cockscomb medicinal powder (pass through a 60-mesh sieve), weigh 5.0 g of dry powder, add 50 ml of 95% ethanol, accurately weigh the mass, ultrasonically extract for 60 minutes, cool, weigh the mass again, and make up the lost mass with solvent, shake well, filter, make up to the volume in a 25 ml volumetric flask with methanol, filter, and take the filtrate.

[0278] Method 3: Accurately weigh 2.5 g of cockscomb slice powder (passed through a 100-mesh sieve), place it in a 50-ml conical flask with a stopper, accurately add 20 ml of water, stopper, weigh, and ultrasonically treat (power 250 W, frequency 40 kHz) for 40 min. Cool, weigh, make up the lost weight with water, filter, and pass the filtrate through a 0.45 μm microporous filter membrane to obtain the test solution.

[0279] Comparing the above-mentioned method for preparing the test solution with the method for preparing the test solution in this case, the prepared test solution was measured using the chromatographic conditions in this case. The difference can be clearly seen from the characteristic spectrum obtained and the characteristic spectrum of the standard product in this case. This shows that the chemical composition is different when the extraction method is different, and the separation and response values ​​of the compound components targeted by the chromatographic conditions are also different. See Figures 25 to 28 It can be seen that the chromatographic compound information obtained by the method in this case is more comprehensive, and the chromatographic separation and response value are better.

[0280] All documents mentioned in this application are cited as references in this application, just as each document is cited as reference separately. Unless they conflict with the application purpose and / or technical solution of this application, the cited documents involved in this application are cited with all contents and all purposes. When the cited documents are involved in this application, the definitions of relevant technical features, terms, nouns, phrases, etc. in the cited documents are also cited. When the cited documents are involved in this application, the examples and preferred methods of the cited relevant technical features can also be incorporated into this application as references, but are limited to the implementation of this application. It should be understood that when the cited content conflicts with the description in this application, the present application shall prevail or be modified adaptively according to the description of this application.

[0281] The technical features of the above-mentioned implementation modes and examples can be combined in any appropriate manner. To make the description concise, not all possible combinations of the technical features in the above-mentioned implementation modes and examples are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0282] The above-described embodiments only express several implementation methods of the present application, but they cannot be understood as limiting the scope of the patent application. It should be pointed out that, for those of ordinary skill in the art, without departing from the concept of the present application, several variations and improvements can also be made, which all belong to the protection scope of the present application. In addition, it should be understood that after reading the above-mentioned teaching content of the present application, those skilled in the art can make various changes or modifications to the present application, and the equivalent forms obtained also fall within the protection scope of the present application. It should also be understood that the technical solutions obtained by those skilled in the art on the basis of the technical solutions provided in the present application through logical analysis, reasoning or limited experiments are all within the protection scope of the claims attached to the present application. Therefore, the protection scope of the patent of the present application shall be based on the attached claims, and the description and drawings may be used to explain the contents of the claims.

Claims

1. A method for constructing a characteristic spectrum of a Chinese medicinal material of Amaranthaceae or its preparation, characterized in that: The steps include: Take the standard sample of ferulic acid, add solvent to dissolve it, and prepare the reference solution. Take a test sample, add an extraction solvent to extract, and prepare a test sample solution, wherein the test sample is selected from a Chinese medicinal material of the Amaranthaceae family or a preparation thereof, The reference solution and the test solution are subjected to high performance liquid chromatography analysis. Wherein, the conditions of the HPLC analysis include: Gradient elution was performed using methanol as mobile phase A and a phosphoric acid aqueous solution with a volume concentration of 0.08% to 0.12% as mobile phase B. The procedure of the gradient elution included: 0-7min, the volume percentage of the mobile phase A is maintained at 20%, 7min~20min, the volume percentage of the mobile phase A increases from 20% to 24%, 20min~30min, the volume percentage of the mobile phase A increases from 24% to 28%, 30min to 50min, the volume percentage of the mobile phase A increases from 28% to 43%, 50min~53min, the volume percentage of the mobile phase A is maintained at 43%, From 53min to 58min, the volume percentage of the mobile phase A increased from 43% to 65%.

2. The method for constructing a characteristic spectrum according to claim 1, characterized in that: The Amaranthaceae Chinese medicinal materials or preparations thereof include: cockscomb medicinal materials, cockscomb standard decoction, cockscomb Chinese medicinal formula granules, agavaceae flower medicinal materials, agavaceae flower standard decoction and agavaceae flower Chinese medicinal formula granules.

3. The method for constructing a characteristic spectrum according to claim 1, characterized in that: The conditions for the HPLC analysis also include at least one of the following: (1) The detection wavelength is 280nm~290nm, (2) Column temperature is 38°C to 42°C; (3) Flow rate: 0.28 mL / min to 0.32 mL / min, (4) The injection volume is 1 μL to 3 μL; (5) The chromatographic column is filled with octadecylsilane bonded silica gel.

4. According to the method for constructing a characteristic spectrum according to claim 3, the inner diameter of the chromatographic column is 2 mm to 2.2 mm, the column length is 140 mm to 160 mm, and the particle size is 1.7 μm to 1.9 μm.

5. The method for constructing a characteristic spectrum according to claim 1, characterized in that: The extraction solvent is an alcohol-water mixture with an alcohol volume ratio of 60% to 80%; The extraction method is ultrasound and / or heating reflux.

6. The method for constructing a characteristic spectrum according to claim 5, characterized in that: The test solution is prepared by comprising the following steps: Taking the test sample, adding the extraction solvent to perform a first extraction, separating the solid and the liquid to obtain a first liquid, evaporating the first liquid, adding the extraction solvent to perform a second extraction, separating the solid and the liquid to obtain a second liquid, The solid-liquid separation method is centrifugation and / or filtration.

7. A method for identifying Amaranthaceae Chinese medicinal materials or their preparations, characterized in that: The steps include: A Chinese medicinal material of Amaranthaceae or its preparation is taken, and a characteristic spectrum of the standard product is constructed according to the characteristic spectrum construction method according to any one of claims 1 to 6. Take the sample to be tested, add an extraction solvent to extract it, and prepare a sample solution, wherein the sample to be tested is selected from Amaranthaceae Chinese medicinal materials or preparations thereof, The sample solution is subjected to high performance liquid chromatography analysis to obtain a characteristic spectrum of the sample. Comparing the characteristic spectrum of the standard substance with the characteristic spectrum of the substance to be tested, Wherein, the conditions of the HPLC analysis include: Gradient elution was performed using methanol as mobile phase A and 0.08-0.12% volume concentration of phosphoric acid aqueous solution as mobile phase B. The procedure of the gradient elution includes: 0-7min, the volume percentage of the mobile phase A is maintained at 20%, 7min~20min, the volume percentage of the mobile phase A increases from 20% to 24%, 20min~30min, the volume percentage of the mobile phase A increases from 24% to 28%, 30min to 50min, the volume percentage of the mobile phase A increases from 28% to 43%, 50min~53min, the volume percentage of the mobile phase A is maintained at 43%, From 53min to 58min, the volume percentage of the mobile phase A increased from 43% to 65%.

8. The identification method according to claim 7, characterized in that: The Amaranthaceae Chinese medicinal materials or preparations thereof include: cockscomb medicinal materials, cockscomb standard decoction, cockscomb Chinese medicinal formula granules, agavaceae flower medicinal materials, agavaceae flower standard decoction and agavaceae flower Chinese medicinal formula granules.

9. The identification method according to claim 7, characterized in that: The conditions for the HPLC analysis also include at least one of the following: (1) The detection wavelength is 280nm~290nm, (2) Column temperature is 35℃~45℃, (3) Flow rate: 0.25 mL / min to 0.35 mL / min, (4) The injection volume is 1 μL to 3 μL. (5) The chromatographic column is filled with octadecylsilane bonded silica gel.

10. The method for constructing a characteristic spectrum according to claim 9, wherein the inner diameter of the chromatographic column is 2 mm to 2.2 mm, the column length is 140 mm to 160 mm, and the particle size is 1.7 μm to 1.9 μm.

11. The method for constructing a characteristic spectrum according to claim 7, characterized in that: The extraction solvent is an alcohol-water mixture with an alcohol volume ratio of 60% to 80%; The extraction method is ultrasound and / or heating reflux.

12. The method for constructing a characteristic spectrum according to claim 11, characterized in that: The test solution is prepared by comprising the following steps: Taking the test sample, adding the extraction solvent to perform a first extraction, separating the solid and the liquid to obtain a first liquid, evaporating the first liquid, adding the extraction solvent to perform a second extraction, separating the solid and the liquid to obtain a second liquid, The solid-liquid separation method includes centrifugation and / or filtration.

Citation Information

Patent Citations

  • Construction method for HPLC characteristic fingerprint spectrum of celosia cristata, and flavonoid component content determination method

    CN110441445A

Cited By

  • Celosia cristata and preparation variable wavelength UPLC characteristic spectrum construction method and application thereof

    CN119470758A